INHIBITOR THERAPEUTICS INC

inhibitor-therapeutics-inc-logo

Inhibitor Therapeutics Inc is a pharmaceutical company focusing on developing therapies for cancerous and non-cancerous treatments.

#Website #More

INHIBITOR THERAPEUTICS INC

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
1992-01-01

Address:
Tampa, Florida, United States

Country:
United States

Website Url:
http://www.inhibitortx.com

Total Employee:
1+

Status:
Active

Contact:
813.509.2420

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome


Official Site Inspections

http://www.inhibitortx.com

  • Host name: hwsrv-453764.hostwindsdns.com
  • IP address: 23.254.134.180
  • Location: Seattle United States
  • Latitude: 47.4902
  • Longitude: -122.3004
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98168

Loading ...

More informations about "Inhibitor Therapeutics Inc"

Inhibitor Therapeutics | Who We Are

Dec 13, 2022 Our Story Inhibitor Therapeutics, we are a publicly traded, clinical stage pharmaceutical development company. We have a focus on developing and commercializing …See details»

Company Information :: Inhibitor Therapeutics, Inc. (INTI)

Inhibitor Therapeutics is a publicly traded, clinical stage pharmaceutical development company. We have a focus on developing and commercializing innovative therapies, using repurposed, already approved API’s (active …See details»

Inhibitor Therapeutics Inc - Crunchbase Company Profile & Funding

Inhibitor Therapeutics Inc is a pharmaceutical company focusing on developing therapies for cancerous and non-cancerous treatments.See details»

Inhibitor Therapeutics (INTI) Company Profile & Description

May 9, 2025 Company profile for Inhibitor Therapeutics, Inc. (INTI) with a description, list of executives, contact details and other key facts.See details»

Inhibitor Therapeutics | Contact Us

CAUTION NOTICE REGARDING FRAUDULENT RECRUITMENT This is to notify the public that certain unscrupulous persons, purporting to be part of and/or being authorized by the human …See details»

INHIBITOR Therapeutics, Inc. - VentureRadar

"Inhibitor Therapeutics, we are a publicly traded, clinical stage pharmaceutical development company. We have a focus on developing and commercializing innovative therapies, using …See details»

Inhibitor Therapeutics Company Profile - Craft

Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and …See details»

Board Committees :: Inhibitor Therapeutics, Inc. (INTI)

Overview News & Events Company Info Financial Info Stock Data SEC Filings GovernanceSee details»

Inhibitor Therapeutics, Inc. (INTI)

Inhibitor Therapeutics is a publicly traded, clinical stage pharmaceutical development company. We have a focus on developing and commercializing innovative therapies, using repurposed, …See details»

inhibitortx.com Reviews: Is this site a scam or legit?

Is inhibitortx.com legit or a scam? Read reviews, company details, technical analysis, and more to help you decide if this site is trustworthy or fraudulent.See details»

Inhibitor Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Inhibitor Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 9 news, and 6 literature, Disease Domain:Hemic ...See details»

Inhibitor Therapeutics | Pipeline

Inhibitor Therapeutics, Inc. (“INHIBITOR”) is a pharmaceutical development company focused on developing and commercializing innovative therapies based on already approved active …See details»

Inhibitor Therapeutics | Management

Director of Regulatory Affairs AMY MCCORD, PHD Lead authoring and strategy for regulatory dossiers including DMFs, INDs, ANDAs, NDAs, BLAs, MAAs, NDS Provide risk-based …See details»

Corporate Governance :: Inhibitor Therapeutics, Inc. (INTI)

Overview News & Events Company Info Financial Info Stock Data SEC Filings GovernanceSee details»

Press Releases :: Inhibitor Therapeutics, Inc. (INTI)

Oct 31, 2019 INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate CancerSee details»

Governor Abbott Announces NTxBio Facility In Plano

4 days ago May 14, 2025 | Austin, Texas | Press Release Governor Greg Abbott today announced that NTxBio (“NTx”) will establish a biomanufacturing facility in Plano. The project …See details»

Inhibitor Therapeutics | Board of Directors

MIKE JERMAN Previously a CFO of multiple private equity-backed companies in the energy, SaaS, and manufacturing industries; was a Director with PwC in the US and UK; was a …See details»

Inhibitor Therapeutics | Scientific Advisory Board

The Gorlin Syndrome Alliance (a non-for-profit independent patient advocacy organization) (GSA) conducted an EL-PFDD (externally led patient focused drug development) meeting on October …See details»

Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory …

The Gorlin Syndrome Alliance (a non-for-profit independent patient advocacy organization) (GSA) conducted an EL-PFDD (externally led patient focused drug development) meeting on October …See details»

Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins ...

Dec 13, 2023 A critical milestone completed on the mission path of commercializing Itraconazole in numerous oncology indications. TAMPA, Fla., Dec. 13, 2023 /PRNewswire/ -- Inhibitor …See details»